|
401 |
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac
Enthalten in EJNMMI radiopharmacy and chemistry Bd. 10, 4.4.2025, Nr. 1, date:12.2025: 1-21
|
|
|
|
402 |
Integrating social and ecological considerations in floodplain relocation and restoration programs
Enthalten in Socio-ecological practice research Bd. 5, 4.5.2023, Nr. 3, date:9.2023: 239-251
|
|
|
|
403 |
Invited reply to the letter to the editor by McNally et al., 2021
Enthalten in BMC musculoskeletal disorders Bd. 22, 8.3.2021, Nr. 1, date:12.2021: 1-3
|
|
|
|
404 |
Irrigation of the intramedullary channel improves outcome of DAIR in a sheep model
Enthalten in npj Biofilms and Microbiomes Bd. 11, 24.2.2025, Nr. 1, date:12.2025: 1-12
|
|
|
|
405 |
Isolation of soybean protein P34 from oil bodies using hydrophobic interaction chromatography
Enthalten in BMC biotechnology Bd. 8, 11.3.2008, Nr. 1, date:12.2008: 1-11
|
|
|
|
406 |
Key aspects of soft tissue management in fracture-related infection: recommendations from an international expert group
Enthalten in Archives of orthopaedic and trauma surgery Bd. 144, 3.11.2023, Nr. 1, date:1.2024: 259-268
|
|
|
|
407 |
Knee arthrodesis versus above-the-knee amputation after septic failure of revision total knee arthroplasty: comparison of functional outcome and complication rates
Enthalten in BMC musculoskeletal disorders Bd. 18, 13.11.2017, Nr. 1, date:12.2017: 1-7
|
|
|
|
408 |
Letter in response to: Identifying risk in the use of tumor markers to improve patient safety
Enthalten in Clinical chemistry and laboratory medicine Bd. 54, 2016, Nr. 12: e383-e384. 2 S.
|
|
|
|
409 |
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
Enthalten in Nature medicine Bd. 29, 3.4.2023, Nr. 5, date:5.2023: 1092-1102
|
|
|
|
410 |
Mapping the band structure of GeSbTe phase change alloys around the Fermi level
Enthalten in Communications Physics Bd. 1, 22.2.2018, Nr. 1, date:12.2018: 1-11
|
|
Administration
